Among cathinone drugs known as bath salts, methylenedioxypyrovalerone (MDPV) exerts its potent actions via the dopamine (DA) system, and at intoxicating doses may produce adverse behavioral effects. Previous work by our group suggests that prolonged alterations in correlated neural activity between cortical and striatal areas could underlie, at least in part, the adverse reactions to this bath salt drug. In the present study, we assessed the effect of acute MDPV administration on brain functional connectivity at 1 and 24 h in rats. Using graph theory metrics to assess in vivo brain functional network organization we observed that 24 h after MDPV administration there was an increased clustering coefficient, rich club index, and average path length. Increases in these metrics suggests that MDPV produces a prolonged pattern of correlated activity characterized by greater interactions between subsets of high degree nodes but a reduced interaction with regions outside this core subset. Further analysis revealed that the core set of nodes include prefrontal cortical, amygdala, hypothalamic, somatosensory and striatal areas. At the molecular level, MDPV downregulated the dopamine transporter (DAT) in striatum and produced a shift in its subcellular distribution, an effect likely to involve rapid internalization at the membrane. These new findings suggest that potent binding of MDPV to DAT may trigger internalization and a prolonged alteration in homeostatic regulation of DA and functional brain network reorganization. We propose that the observed MDPV-induced network reorganization and DAergic changes may contribute to previously reported adverse behavioral responses to MDPV.
Introduction
Methylenedioxypyrovalerone (MDPV) is an illicit psychoactive synthetic drug present in street formulations known as "bath salts". MDPV is a potent psychostimulant with high abuse liability, producing greater psychomotor stimulant effects than cocaine (Baumann et al., 2012) . Rodent studies have shown that MDPV elevates striatal extracellular dopamine (DA) by blocking transportermediated DA uptake (Cozzi et al., 1999; Simmler et al., 2012) and it has also been shown to cause efflux of DA possibly through the DA transporter (DAT) (Shekar et al., 2017) , encoded in humans by the SLC6A3 gene (Kawarai et al., 1997; Vandenbergh et al., 1992) . Based on significant evidence, however, MDPV is largely recognized as a reuptake blocker, but not a releasing agent (Baumann et al., 2013; Cameron et al., 2013) . Elevated extracellular DA is thought to mediate the potent psychomotor, reinforcing and euphorigenic effects of MDPV .
In addition to the euphorigenic effects, a considerable number of clinical case reports indicate that MDPV intoxication is associated with adverse behavioral and physiological effects (White, 2016) (Beck et al., 2015; Elliott and Evans, 2014; Spiller et al., 2011; Vallersnes et al., 2016) . In reports confirming MDPV in either urine or serum, the adverse effects include agitation, tachycardia, hallucinations, delirium, hyperthermia and rhabdomyolysis (Beck et al., 2015; Spiller et al., 2011) , psychosis (Vallersnes et al., 2016) , suicidal ideation (Elliott and Evans, 2014) , and aggressive behavior (Diestelmann et al., 2018) . As occurs with chronic use of intoxicating doses of other potent stimulants (American Psychiatric Association and American Psychiatric Association DSM-5 Task Force, 2013; Mash, 2016) , binge MDPV use can also cause excited delirium (Karila et al., 2018) . A molecular mechanism that may contribute to such adverse effects of MDPV is the downregulation of striatal DAT, which has been previously observed in postmortem samples taken from chronic cocaine users that experienced excited delirium and sudden death (Mash et al., 2009) . MDPV exerts potent inhibitory actions on DAT and on DAT-mediated outward currents in oocytes expressing human DAT (hDAT) , and concentrates at high levels in rat striatum for prolonged periods after administration (Novellas et al., 2015) . Such potent and prolonged molecular actions of MDPV on DAT could result in downregulation, as observed with other amphetamines (Cervinski et al., 2005; Goodwin et al., 2009; Richards and Zahniser, 2009 ). Altered striatal DA activity, as result of DAT downregulation, can in turn modify functional interactions between the striatum and sensory, motor, limbic cortical regions and downstream midbrain and thalamic brain areas (Ahmadlou et al., 2013; Cole et al., 2013; Konova et al., 2013) . In the present study, a series of experiments were carried out to determine the prolonged effects of acute MDPV exposure on striatal DAergic mechanisms, functional connectivity and behaviors indicative of rats' affective state.
We previously used functional magnetic resonance imaging (fMRI) and seed-based functional connectivity analysis to show that MDPV exerts disruptive effects on functional connectivity in rat brain 1 h after administration (Colon-Perez et al., 2016) . To determine the prolonged effects of MDPV on functional connectivity, in the present study we imaged rats 24 h after administration and utilized graph analysis to assess the topology of functional connectivity networks 24 h after MDPV. Graph theory analysis of resting state fMRI offers a means to quantitatively define the arrangement of functional correlations between brain regions and has been successfully applied to functional connectivity studies of cocaine, heroin, methamphetamine and alcohol use disorders (Jiang et al., 2013; Sjoerds et al., 2017; Wang et al., 2015) . Here, we identified alterations to this organizational pattern of functional connectivity in rat brain that lasted at least 24 h after MDPV. In addition, MDPV downregulated striatal DAT and shifted the subcellular distribution of this protein, and behavioral tests showed a modest but significant reduction in social interactions.
Materials and methods

Subjects
Adult Long Evans male rats (n ¼ 156; 250e300 grams at the start of the experiments) were purchased from Charles River Laboratories (Raleigh, North Carolina) and were housed in pairs in a temperature and humidity-controlled vivarium (12 h light-dark cycle, with lights off at 1900h). Food and water were available ad libitum. Experiments and procedures received prior approval by the Institutional Animal Care and Use Committee of the University of Florida and followed all applicable NIH guidelines.
Functional magnetic resonance imaging
Rats were imaged under combined dexmedetomidine (0.02 mg/ kg intraperitoneal)/isoflurane (0.5%) sedation (delivered in 70%N 2 / 30%O 2 at 0.1L/min), as previously described (Lu et al., 2007) , with additional modifications (Colon-Perez et al., 2016) . To minimize effects of repeated anesthesia in a 24 h period of imaging, we scanned a subgroup of rats at 1 h and a separate group of rats at 24 h. Spontaneous breathing was monitored and recorded during MRI acquisition (SA Instruments, Stony Brook, NY). Body temperature was maintained at 37e38 C using a warm water recirculation system (Biopac Systems, Inc). A 2-shot spin echo echo planar imaging sequence was acquired using the following parameters: TR/ TE ¼ 1000/50 ms, and 210 repetitions for a total acquisition time of 7.5 min (an image was acquired every 2s), FOV ¼ 32. hour ¼ 8, n 24 h ¼ 12), or saline (n 1 hour ¼ 7, n 24 h ¼ 11). These rats were only used for imaging and did not undergo any behavioral testing. Acquisition ad processing of fMRI datasets were as reported previously (Colon-Perez et al., 2016) .
Image processing
Brain masks were drawn manually over high resolution anatomical scans using image segmentation tools in ITK-SNAP (www.itksnap.org). The whole brain masks were used to crop images and remove non-brain voxels. The cropped brain images were aligned with a rat brain template using the FMRIB Software Library linear registration program flirt (Jenkinson et al., 2002) , using previously published parameters (Colon-Perez et al., 2016) . Registration matrices were saved and used to subsequently transform functional datasets into atlas space for preprocessing and analysis. Displacements in individual images over the series of 210 images and slice timing delays were corrected, and time series spikes were removed using Analysis of Functional NeuroImages (AFNI) (Cox, 1996) . Detrending, spatial blurring (1.1 mm FWHM), and intensity normalization were performed. Head-motion parameters and cerebroventricular and white matter signals were extracted based on their location in the segmented atlas and were removed from all datasets. A voxelwise temporal band-pass filter (between 0.01 Hz and 0.1 Hz) was applied.
Time series fMRI signals were extracted from each region of interest (ROI) based on the atlas-guided seed location (150 total areas, equally divided in left and right representations of each region). Signals were averaged from voxels in each ROI (Colon-Perez et al., 2016) . Voxel-wise cross correlations were carried out to create correlation coefficient (Pearson r) maps. The first 9 images in each functional time series were not used in the cross-correlation step. Pearson r coefficients per ROI were subjected to a voxelwise z-transformation and exported for network analyses in Matlab.
Network analysis
Brain connectivity networks were analyzed using the Brain Connectivity Toolbox for Matlab (Rubinov and Sporns, 2010) .
Symmetrical connectivity graphs with a total 11,175 matrix entries were first organized in Matlab [graph size ¼ n(n-1)/2, where n is the number of nodes represented in the graph, or 150 ROI]. The z score values of the graphs were thresholded for each subject to create matrices with equal densities (e.g., z values in the top 15% of all possible correlation coefficients). Matrix z values were normalized by the highest z-score, such that all matrices had edge weight values ranging from 0 to 1. This approach was found in our hands to minimize the impact of between-subject variations in correlation values on the final results. Node strength (sum of edge weights), clustering coefficient (the degree to which nodes cluster together in groups), average shortest path length (the potential for communication between pairs of structures), rich club (the likelihood of connectivity among high degree nodes) and small worldness (the degree to which rat functional brain networks under study deviate from randomly connected networks) were calculated for weighted graphs (Boccaletti et al., 2006; Humphries and Gurney, 2008; Newman, 2003; Saramaki et al., 2007) .
The small world arrangement of edges connecting node pairs in graphs (i.e., graph topology) was determined by comparing rat brain network organization to an average of ten null-hypothesis networks per rat (Watts and Strogatz, 1998) . This comparison of rat brain and null graphs was used to analyze clustering coefficients and path lengths. The ratio of clustering coefficient from rat brain networks to null networks is known as g. For a small world network this parameter is larger than 1, which is indicative of larger local connectivity than that of a network connected by randomly assigned edges (Humphries and Gurney, 2008) . The ratio of average path length in rat brain networks to null networks is referred to as l. For a small world network this parameter is close to 1. The small world (sw) parameter is the ratio of g/l, with a sw > 1 indicative of small world topology (typical of real world networks) and sw~1 indicative of a random network (Erd€ os and R enyi, 1960) .
Brain networks were visualized using BrainNet Viewer (Xia et al., 2013) . The 3D networks were generated with undirected edges weights E undir ! 0.3. In these brain functional networks, the node size and color is scaled by the node strength and edges are scaled by z-scores. Network measures were analyzed by a twofactor analysis of variance (ANOVA), with treatment drug condition (i.e. dose of MDPV) and day time point (i.e. day) as independent factors (significance at p < 0.05). Benjamin-Hochberg false discovery rate correction was used for post hoc multiple comparison tests (Matlab).
Subcellular fractionation
Rats were administered saline, 1, or 3 mg/kg MDPV (i.p.) and sacrificed 24 h later (n ¼ 8 rats/group). These rats were only used for immunoblotting and did not undergo imaging or behavioral testing. Dissected striata were subjected to subcellular fractionation methods according to previous work (Rao et al., 2011) . Rats were decapitated, brains extracted and flash frozen in powdered dry ice and stored at À80 C until the day of assay. Briefly, following decapitation the striatum was dissected and between 0.10 and 0.15 g of tissue was homogenized in 1.5 mL of ice cold PBS containing 0.32 M sucrose and 20 mM HEPES, 1 mM EGTA, 1 mM EDTA, and protease inhibitors. The homogenate was centrifuged at 1000 Â g for 10 min and the pellet discarded. The supernatant (total protein extract) was spun at 12,500 Â g for 20 min at 4 C. The resulting synaptosomal pellet was fractionated using differential fractionation (Online Fig. S3 ). Synaptosomes were lysed in hypotonic media on ice for 45 min and centrifuged at 2000 Â g for 20 min. The supernatant was sequentially centrifuged at 32,000 Â g for 1 h and 100,000 Â g for 2 h to obtain P2 (endosomal fractions) and P3 pellets (synaptic vesicle fraction), respectively. The remaining supernatant was termed S3 (cytoplasmic fraction). All the previously mentioned steps of centrifugation were carried out at 4 C using a TLA55 Beckman rotor. Protein concentrations of all the fractions were measured using the DC™ protein assay (BioRad), and equal amounts of total protein were loaded on a 10% SDS PAGE gel and immunoblotted for specific antigens: anti-DAT (1:1000; sc-1433, Santa Cruz Biotechnology), anti-TH (1:1000; AB5935, Chemicon), VMAT2 (1:1000; 2200-VMAT2C, Phosphosolutions) (Supplemental Fig. S4 ). Quantification of relative levels of DAT, TH, and VMAT2 in each subcellular compartment (i.e. synaptosomal, plasma membrane, endosomal, synaptic vesicles, and cytoplasmic fractions) was carried out by normalizing each protein immunoblot signal by the signal of their corresponding total extracted protein (Supplemental Fig. S4 ). For each MDPV dose group, comparisons were made to a control (saline) group included in the same immunoblot. Immunoblots were run on each sample at least 6 times. Data were analyzed using a two-way ANOVA and Bonferroni's post hoc test (a ¼ 0.05).
Immunoblots
For immunoblots, 30 mg of rat striatal protein samples were separated by SDS-PAGE on 10% Tris-HCl polyacrylamide gels and transferred to nitrocellulose membranes using the Bio-Rad system. The nitrocellulose membranes were first blocked for 1 h in TBS-T buffer (50 mM Tris-HCl, 150 mM NaCl, 0.2% Tween 20) containing 5% dry milk and then incubated with the indicated primary antibody for 2 h at RT in blocking buffer, washed three times for 5 min each, and incubated with an HRP-conjugated secondary antibody (dilution 1:5000) for 1 h at room temperature in blocking buffer. After all antibody incubations, membranes were washed thrice with TBS-T buffer and protein bands were visualized using the Clarity™ Western ECL Substrate (Bio-Rad), and blots were quantified and normalized by Ponceau S staining (total protein stain) with ImageJ software (version 1.49v, NIH, USA). Data were analyzed using a two-way ANOVA and Bonferroni's post hoc test (a ¼ 0.05).
High performance liquid chromatography (HPLC) detection of dopamine and its metabolites
Total striatal rat brain homogenate (the total protein fraction) was diluted five times in a solution of 0.1 M perchloric acid and transferred to 0.2 mm Nanosep ® polypropylene centrifugal filter units (Pall, Port Washington, NY) and centrifuged at 5000 Â g at 4 C for 5min for further purification. Samples were stored at À80 C until analyzed for dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) using HPLC coupled with electrochemical detection. Aliquots (5 mL) of each sample were injected onto a C18 column (Acquity UPLC BEH C18, 1.7 mm, 1 Â 100 mm, Waters, Milford, MA) using a mobile phase consisting of 100 mM phosphoric acid, 100 mM citric acid, 0.1 mM EDTA.Na2, 600 mg/L octane sulfonic acid sodium salt, and 8% acetonitrile (v/v), at pH3.0. The mobile phase was pumped through the system at 50 ml/ min using an ANTEC LC 110S pump (Antec, Zoeterwoude, the Netherlands). Analytes were detected using an ANTEC DECADE Elite electrochemical detector (Antec, Zoeterwoude, the Netherlands) with a SenCell flow cell with a 2 mm glassy carbon working electrode (Antec, Zoeterwoude, the Netherlands). Detection for DA and its metabolites were identified relative to the retention times set to known standards, and results were expressed as nmol of neurotransmitter normalized to the total amount of protein.
Dopamine transporter (DAT) assay
Synthetic human DAT (hDAT; SLC6A3; provided by Dr. Jonathan Javitch, Columbia University) was used in this assay. Human Embryonic Kidney (HEK) cells stably expressing DAT tagged with yellow fluorescent protein (HEK-YFP) were plated on poly-D-lysine coated glass-bottomed dishes (MatTek No. 0) (Richardson et al., 2016) . The YFP-hDAT was constructed by fusing the N-terminus of synthetic hDAT cDNA to the C-terminus of the coding region of enhanced YFP from pEYFP-N1 (Clontech). The cells we used were EM4 cells. These cells were generated by stable transfection of macrophage scavenger receptor into HEK293 cell line. The EM4 cells were then stably transfected with YFP-hDAT to generate a stably transfected cell line (Carvelli et al., 2002; Kahlig et al., 2004) . The cells grew up to 70e80% confluency. On the day of the experiment, cells were gently washed thrice with warm external solution (146 mM NaCl, 5 mM KCl, 30 mM dextrose, 5 mM HEPES, 1.2 mM MgCl 2 $6H 2 O and 2.5 mM CaCl 2 $2H 2 O, pH 7.4 and 290 mOsm) to remove the media. The cells were then allowed to incubate in the external solution for 15e20 min before imaging. Live-cell imaging was performed at 37 C using a Nikon Eclipse Ti confocal microscope. Cells were imaged before (0 min) and after (60 min) drug application (vehicle, 0.3 mM of cocaine, MDPV, and methamphetamine). Fluorescent intensity (Fi) inside the cells was analyzed using Nikon NIS element software. Percent change in fluorescent intensity in the cytoplasm was calculated using the formula:
Data were analyzed using a one-way ANOVA (a ¼ 0.05).
Social interaction test
To assess affective behavioral outcomes 24 h after MDPV administration, we conducted tests for social interaction and ultrasonic vocalizations (USVs) in animals given saline or one of two doses of MDPV (1 and 3 mg/kg). Rats were first handled and acclimated to the room and test arena for 4 days before experiments. Testing was conducted in a room with minimal noise. The test arena consisted of a clear Plexiglas box (40 cm 3 ) located directly below a digital camera used to stream and record behavior sessions for offline scoring. All internal and external visual cues were maintained constant. Two separate and independent reviewers scored behavioral responses using Odlog software (Macropod Inc.). Data from two trained reviewers were analyzed individually to verify consistency. Reviewers used practice video under trainer guidance and conducted several rounds of scoring to ensure accuracy and precision. Data were then averaged before final statistical analysis. A social interaction test was performed in three groups of rats given i.p. injections of saline, MDPV 1 mg/kg or 3 mg/kg (n ¼ 6 per group), using procedures described previously (Felix-Ortiz and Febo, 2012) . These rats were only used in social interaction tests. For social interaction experiments, twelve juvenile male rats used as a social stimulus during testing (125e190 g; Charles River Labs, Raleigh, NC) were handled and acclimated to the test arena and room to minimize stress in both test and stimulus rats (Felix-Ortiz and Febo, 2012) . Twenty-four hours before the 1st test trial, rats received a single injection of saline or MDPV (i.p.). During the first test trial, test rats were placed into the test arena containing the smaller stimulus male rat. Animals remained in the arena for 3 min and were then returned to their home cages. One hour after this test, a second 3-minute test was performed with the same juvenile to assess social recognition. Anogenital exploration of the smaller stimulus rat was scored in test rats as a measure of social interest and recognition. A two-way ANOVA with repeated measure (test session 1 vs 2) and Sidak's post hoc tests were used for statistical comparisons between saline and MDPV treated rats (a ¼ 0.05).
Ultrasonic vocalizations (USVs)
USVs were recorded at 1 and 24 h after administration of saline (n ¼ 8), 1 (n ¼ 8) and 3 mg/kg MDPV (n ¼ 6). These rats were only used for USV recordings. The test arenas used for recordings consisted of plastic clear boxes similar to the dimensions of the rats' home cages. These contained bedding and were covered by a wire mesh lid that allowed sound to be detected from above at a 30-cm distance (Felix-Ortiz and Febo, 2012) . USVs were recorded at 1 and 24 h after administration of saline (n ¼ 8), 1 (n ¼ 8) and 3 mg/kg MDPV (n ¼ 6). Two minutes of recordings were collected at each time point. USVs were recorded using a condenser microphone sensitive to 0e200 kHz frequencies (Dodotronic ultramic200k) and SeaPro Analyzer/Recorder software. These were continuously monitored using a frequency window between 0 and 100 kHz, and spectrograms were generated online using a Fast Fourier Transform size of 512, a sampling rate of 200 kHz, 16-bit data format. A Hamming filter was used to reduce background noise. A trained reviewer quantified total number of spectrogram waveforms in the 50 kHz frequency at each time point, using SeaWave analysis software. All noises shorter than 10 ms, with bandwidths shorter than 1 Hz, or bandwidths greater than 6 Hz, were excluded. A two-way ANOVA with repeated measures and Dunnett's post hoc tests were used for statistical comparisons between saline and MDPV treated rats (a ¼ 0.05).
Intracranial self-stimulation (ICSS)
ICSS thresholds were assessed at several different times points after injections: 1, 6 and 24 h after i.p. administration of saline (n ¼ 6) or 3 mg/kg MDPV (n ¼ 6). This group of rats were only used for ICSS experiments. The surgical procedures were conducted as described previously by our group (Bruijnzeel et al., 2010; Qi et al., 2016) . Rats were trained on a modified discrete-trial ICSS procedure as described previously (Bruijnzeel et al., 2009; Markou and Koob, 1992; Qi et al., 2016) . Rats were prepared with electrodes in the medial forebrain bundle and trained on the ICSS procedure. When the ICSS thresholds were stable (<10% variation over 5-day period) the rats received MDPV (3 mg/kg, i.p.) or saline, 10 min before ICSS testing. The drugs were administered using a within-subjects design, with the order of administration randomized across rats. The rats were anesthetized with isoflurane and prepared with electrodes (Plastic One, Roanoke, VA) in the medial forebrain bundle (anterior-posterior À0.5 mm; medial lateral ±1.7 mm; dorsal-ventral À8.3 mm from dura). The electrodes were permanently secured to the skull using dental cement anchored and skull screws.
The operant conditioning chambers were housed in soundattenuating chambers (Med Associates, Georgia, VT, USA). The operant conditioning chambers had a 5 cm wide metal response wheel that was centered on a sidewall and a photobeam detector recorded every 90 degrees of rotation. Brain stimulation was delivered by constant current stimulators (Model 1200C, Stimtek, Acton, MA, USA). Each test session provided a brain reward threshold and response latency. The reward threshold was defined as the midpoint between stimulation intensities that supported responding and current intensities that failed to support responding. The response latency was defined as the time interval between the beginning of the non-contingent stimulus and a positive response. Elevations in brain reward thresholds reflect dysphoria (Barr et al., 2002) . Drugs that have sedative effects or induce motor impairments increase the response latency and stimulants decrease the response latency (Igari et al., 2013; Liebman, 1985) . Data were analyzed using a two-way ANOVA and Bonferroni's post hoc test (a ¼ 0.05).
Results
3.1. MDPV reduced the strength of correlated neural activity at 1 h but showed no effect by 24 h
We used node strength as a measure of the strength of correlated activity (e.g., functional connectivity) between each region of interest (ROI). Functional connectivity was assessed at 1 h and 24 h following saline, MDPV or cocaine administration (Fig. 1) . Node strength was significantly reduced by MDPV or cocaine at 1 h (Fig. 1A) . A two-way ANOVA revealed a significant treatment Â time interaction (F 3,70 ¼ 3.8, p ¼ 01), a main effect of time (F 1,70 ¼ 25.3, p < 0.0001) and a main effect of treatment on node strength (F 3,70 ¼ 5.5, p ¼ 0.002). Post hoc tests indicated that at 1 h, cocaine and 1 mg/kg MDPV, but not 3 mg/kg, reduced node strength relative to saline controls (cocaine: t 70 ¼ 4.3, p(FDR) ¼ 0.0003; MDPV 1 mg/kg: t 70 ¼ 3.0, p(FDR) ¼ 0.009; 3 mg/kg: t 70 ¼ 1.4, p(FDR) ¼ 0.3) (Fig. 1B) . Surprisingly, cocaine showed the strongest effect in reducing node strength relative to saline and this was followed by the lowest dose of MDPV. These differences in node strength between saline, MDPV and cocaine groups at 1 h were no longer evident at 24 h (Fig. 1C) . When comparing 1 he24 h time points, we found that there was no difference in node strength between saline at 1 h and 24 h. However, we observed significant differences between 1 h and 24 h time points in rats treated with cocaine (t 70 ¼ 4.9, p(FDR) < 0.0001), 1 mg/kg (t 70 ¼ 2.9, p(FDR) ¼ 0.01), but not 3 mg/kg MDPV (t 70 ¼ 2.3, q ¼ 0.06) (Fig. 1B and D) .
3.2. Network reorganization 24 h after MDPV reflected in high clustering, increased path length, but preserved small world topology characteristic of neural networks
We next used several basic graph theory metrics to assess the organization of nodal interactions in functional connectivity-based graphs. Using these metrics, we determined the degree to which nodes cluster into functional groups (clustering coefficient), the potential for communication between pairs of nodes (average shortest path length) and the degree to which functional networks deviate from randomly interacting networks (small worldness). A Fig. 1 . MDPV shows prolonged effects on graph topology (arrangement of neural interactions) but not node strength (strength of interactions). A) Functional connectivity maps 1 h after saline (red horizontal bar), 15 mg/kg cocaine (orange), MDPV at 1 mg/kg (yellow) or 3 mg/kg (blue). B) Node strength 1 h after treatment (groups same as in A). C) Functional connectivity maps for the same treatment groups shown in A, but at 24 h. The highest dose of MDPV increased connectivity at 24 h. D) Node strength 24 h after treatment (groups same as in A). E) Top: MDPV and cocaine reduced clustering coefficient 1 h post-treatment. Bottom: At 24 h, increased clustering coefficient is observed in both treatment groups. F) Top: MDPV and cocaine reduced path length at 1 h. Bottom: At 24 h, only MDPV increased path length. G) Top: MDPV and cocaine reduced small worldness at 1 h. Bottom: At 24 h, no differences in small worldness are observed between groups. All data presented as Tukey box and whisker plots (median, 25e75th percentile and 1.5 interquartile range). Two-way ANOVA with drug Â day interaction and FDR corrected multiple comparisons tests were used (symbols in top and bottom plots denote p < 0.05 for 1 h or 24 h, respectively; symbols between top and bottom plots compare 1 h vs. 24 h).
two-way ANOVA revealed a significant treatment Â time interaction (F 3,70 ¼ 69.2, p < 0.0001) and main effect of treatment on clustering coefficient (F 3,70 ¼ 47.2, p < 0.0001). Post hoc tests indicated that at 1 h, clustering coefficient was significantly reduced relative saline controls by either dose of MDPV (t 70 ¼ 14.1, p(FDR) < 0.0001 for 1 mg/kg and t 70 ¼ 11.3, p(FDR) < 0.0001 for 3 mg/kg) or cocaine (t 70 ¼ 14.7, p(FDR) < 0.0001) (Fig. 1E, top plot) . At 24 h, the highest dose of MDPV (3 mg/kg) increased clustering coefficient relative to saline (t 70 ¼ 3.5, p(FDR) ¼ 0.002) and cocaine (t 70 ¼ 2.4, p(FDR) ¼ 0.03) (Fig. 1E, bottom plot) . The 1 mg/kg dose of MDPV showed a non-significant trend towards increase clustering relative to saline controls (t 70 ¼ 3.5, p(FDR) ¼ 0.07 and p ¼ 0.05). When comparing clustering coefficient between 1 h and 24 h time points, we observed significant changes in saline (t 70 ¼ 12.6, p(FDR) < 0.0001), cocaine (t 70 ¼ 4.5, p(FDR) < 0.0001), 1 mg/kg (t 70 ¼ 4.5, p(FDR) < 0.0001) and 3 mg/kg MDPV (t 70 ¼ 2.7, p(FDR) ¼ 0.01) groups.
A two-way ANOVA revealed a significant treatment Â time interaction (F 3,70 ¼ 71.9, p < 0.0001), a main effect of time (F 1,70 ¼ 6.9, p ¼ 0.01) and a main effect of treatment on path length (F 3,70 ¼ 50.3, p < 0.0001). Post hoc tests indicated that at 1 h path length was significantly reduced relative to saline controls by either dose of MDPV (t 70 ¼ 14.6, p(FDR) < 0.0001 for 1 mg/kg and t 70 ¼ 12.4, p(FDR) < 0.0001 for 3 mg/kg) or cocaine (t 70 ¼ 14.7, p(FDR) < 0.0001) (Fig. 1F, top plot) . At 24 h, the highest dose of MDPV (3 mg/kg) increased path length relative to saline (t 70 ¼ 2.7, p(FDR) ¼ 0.02) (Fig. 1F, bottom plot) A two-way ANOVA revealed a significant treatment Â time interaction (F 3,70 ¼ 11.4, p < 0.0001) and main effect of treatment on clustering coefficient (F 3,70 ¼ 7.2, p ¼ 0.0003). Post hoc tests indicated that at 1 h the small world index was significantly reduced relative to saline controls by both doses of MDPV (t 70 ¼ 5.3, p(FDR) < 0.0001 for 1 mg/kg and t 70 ¼ 3.9, p(FDR) ¼ 0.0007 for 3 mg/kg) and cocaine (t 70 ¼ 6.3, p(FDR) < 0.0001) (Fig. 1G, top plot) . No differences in small worldness were observed at 24 h (Fig. 1G , bottom plot). When comparing small worldness between 1 h and 24 h time points, we observed significant changes in saline (t 70 ¼ 4.8, p(FDR) < 0.0001) and cocaine treated rats (t 70 ¼ 2.8, p(FDR) ¼ 0.02), but not with MDPV.
MDPV increased rich club network participation at 24 h
There is evidence of a core network of structures, known as a rich club, which include high degree (highly correlated) nodes with a higher-than-predicted density of connections (van den Heuvel et al., 2013) . Axonal tract tracing studies have measured rich club connections in the non-human primate, cat, rat and mouse brains, and in much smaller synaptic networks of~302 neurons of the nematode Caenorhabditis elegans, and recently in in vivo functional MRI networks of anesthetized or awake rats (Bota et al., 2015; de Reus and van den Heuvel, 2013; Harriger et al., 2012; Liang et al., 2017; Ma et al., 2016; Rubinov et al., 2015; Towlson et al., 2013; van den Heuvel et al., 2016) . The effects of drug treatments at 1 h on rich club participation were complex and involved greater subnetwork connectivity relative to saline controls at k values below 20 and a precipitous drop in rich club participation above this index value (Mann-Whitney ANOVA p < 0.05) (Supplemental Fig. S1 ).
At 24 h after MDPV, both doses of MDPV increased rich club participation (k range 19e26) relative to saline controls ( Fig. 2D; Mann-Whitney ANOVA p < 0.05). This was not observed with cocaine treatment and therefore appeared to be selective to MDPV exposure. Due to increased changes in local clustering in striatal, amygdalar, hypothalamic, frontal cortical and sensoricortical nodes we assessed the connectivity between these structures ( Fig. 2A) . Cumulative node strength distribution of these areas (Fig. 2B ) and pairwise group statistical comparisons (Fig. 2C) indicated that the strongest effects on rich club topology were produced by these nodes at the 3 mg/kg dose of MDPV (Mann-Whitney ANOVA p < 0.05).
3.4. Acute MDPV downregulated striatal DAT at 24 h and caused a shift in subcellular levels and distribution of DAT, tyrosine hydroxylase (TH) and vesicular monoamine transporter 2 (VMAT2)
DAT is the primary target of MDPV (Cozzi et al., 1999; Simmler et al., 2012) and downregulation of this protein is hypothesized to contribute to excited delirium in chronic cocaine users (Mash et al., 2009 ). Compared to saline controls, 3 mg/kg MDPV reduced the relative total levels of DAT and VMAT2 protein in striatal tissue (Student's t-test; DAT: t 5 ¼ 3.7 p ¼ 0.01; VMAT2: t 5 ¼ 3.3 p ¼ 0.02) but not TH (Fig. 3AeC) . A change in DAT, TH and VMAT2 was not observed with 1 mg/kg MDPV.
We further assessed subcellular levels of DAT, TH and VMAT2 in striatal synaptosomes (Fig. 4) . For DAT, a two-way ANOVA with repeated measures indicated a significant interaction between subcellular fraction and 3 mg/kg MDPV treatment (F 5,30 ¼ 6.6, p ¼ 0.0003), along with a main effect of subcellular fraction (F 5,30 ¼ 38.4, p < 0.0001) and of MDPV treatment (F 1,30 ¼ 21.4, p < 0.0001). A Bonferroni post hoc test indicated that MDPV increased DAT in plasma membrane (t ¼ 2.9, p < 0.05) and in the endosomal compartment (t ¼ 6.4, p < 0.001) (Fig. 4B) .
For TH, a two-way ANOVA with repeated measures indicated a significant interaction between subcellular fraction and 3 mg/kg MDPV treatment (F 5,30 ¼ 10.8, p < 0.0001), along with a main effect of subcellular fraction (F 5,30 ¼ 29.8, p < 0.0001) and of MDPV treatment (F 1,30 ¼ 33.3, p < 0.0001). A Bonferroni post hoc test indicated that MDPV increased TH in synaptic vesicle (t ¼ 7.4, p < 0.05) and cytoplasmic compartments (t ¼ 5.5, p < 0.001) (Fig. 4B) .
For VMAT2, a two-way ANOVA with repeated measures indicated a significant interaction between subcellular fraction and 3 mg/kg MDPV treatment (F 5,30 ¼ 5.8, p ¼ 0.0007), along with a main effect of subcellular fraction (F 5,30 ¼ 79.5, p < 0.0001) and of MDPV treatment (F 1,30 ¼ 21.5, p < 0.0001). Similar to DAT, a Bonferroni post hoc test indicated that MDPV increased VMAT2 in plasma membrane (t ¼ 3.9, p < 0.05) and in the endosomal compartment (t ¼ 5.2, p < 0.001) (Fig. 4B) .
MDPV at 1 mg/kg affected subcellular levels of TH, but did not affect DAT or VMAT2 levels (Fig. 4A) . A two-way ANOVA with repeated measures indicated a significant interaction between subcellular fraction and 1 mg/kg MDPV treatment (F 5,30 ¼ 3.1, p ¼ 0.02), along with a main effect of subcellular fraction (F 5,30 ¼ 104.7, p < 0.0001) and of MDPV treatment (F 1,30 ¼ 17.5, p ¼ 0.0003). Similar to the higher dose of MDPV, a Bonferroni post hoc test indicated that this lower dose of MDPV increased TH in synaptic vesicle (t ¼ 7.4, p < 0.05) and cytoplasmic compartments (t ¼ 5.5, p < 0.001) (Fig. 4A) .
Acute MDPV increased striatal dopamine metabolism: evidence of altered dopamine homeostasis
Because changes in DAT and subcellular VMAT2 and TH may affect DA turnover, we further assessed striatal DA and its metabolites dihydoxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in MDPV exposed rats (Fig. 5) . Although there was no difference in DA concentration between 1 and 3 mg/kg MDPV vs saline, DOPAC levels were significantly increased with 3 mg/kg MDPV (One way ANOVA F 2,14 ¼ 14.6 p ¼ 0.0004; Dunnett's post hoc test p ¼ 0.003 for saline vs 3 mg/kg MDPV). HVA did not differ between MDPV and saline treated rats, however, 3 mg/kg MDPV had higher levels of HVA than 1 mg/kg treated rats (One way ANOVA F 2,14 ¼ 4.8 p ¼ 0.03; Sidak's post hoc test p ¼ 0.02 for 1 vs 3 mg/kg MDPV). Fig. 2 . MDPV increased rich club network and functional connectivity between cortical, limbic and striatal regions at 24 h. A) Three-dimensional (3D) subnetwork connectomic maps of high degree nodes 24 h after saline (red horizontal bar), 15 mg/kg cocaine (orange), MPDV 1 mg/kg (yellow) or 3 mg/kg (blue). List below maps summarize high degree nodes comprising this subnetwork. B) Cumulative node strength distribution shows greatest subnetwork connectivity for highest dose of MDPV (rightward shifted light blue line). C) 3D statistical plots showing subnetwork connectivity is greatest with the 3 mg/kg MDPV, compared to saline, 1 mg/kg or 15 mg/kg cocaine (p < 0.05 FDR corrected). D) Rich club curve 24 h after treatment (groups in A). Differences in Rich club participation are between 1 and 3 mg/kg MDPV and saline, with no effect of cocaine treatment (MannWhitney test: p < 0.05 for k ¼ 19e25; light grey MDPV 1 mg/kg vs. saline and dark grey for 3 mg/kg MDPV vs. saline; plot error bars are ± standard deviation).
When analyzed in terms of metabolite concentrations relative to DA, we observed that there were significant increases in DOPAC/DA (One way ANOVA F 2,14 ¼ 7.8 p ¼ 0.005; Dunnett's post hoc test p ¼ 0.006 for saline vs 3 mg/kg MDPV) and DOPAC þ HVA/DA One way ANOVA F 2,14 ¼ 5.3 p ¼ 0.02; (Dunnett's post hoc test p ¼ 0.02 for saline vs 3 mg/kg MDPV) (Fig. 5). 3.6. MDPV produces membrane DAT internalization in vivo: potential early cellular mechanism underlying network adaptations
There was a significant effect of treatment on cytosolic YFP signal at 60 min (F 3,410 ¼ 63.7 p < 0.0001). Tukey's multiple comparison post hoc test indicated that methamphetamine caused significant internalization of DAT at 60 min after treatment (q 410 ¼ 17.1 p < 0.0001), while cocaine showed no effect (Fig. 6AeB) . MDPV caused a significant increase in cytosolic fluorescence at 60 min post-treatment, which is consistent with DAT internalization (q 410 ¼ 7.9 p < 0.0001).
MDPV reduced ICSS thresholds at 1 h and this recovered to baseline by 6 h
MDPV doses in the range of 0.5e2 mg/kg produce immediate reductions in intracranial self-stimulation (ICSS) brain reward thresholds (Watterson et al., 2014) . We measured levels of ICSS brain reward thresholds at 1, 6, and 24 h after administration of saline or 3 mg/kg MDPV. MDPV lowered the ICSS thresholds and the effect of MDPV decreased over time (treatment, F 1,16 ¼ 5.88, p < 0.05; treatment x time, F 2,32 ¼ 6.79, p < 0.01) (Fig. 7A) . Post hoc analyses revealed that the ICSS thresholds were decreased 1 h after the administration of MDPV but not at any later time points. The administration of MDPV did not affect the response latencies (Fig. 7B) .
MDPV increased 50 kHz USV calls at 1 h and this recovered to baseline by 24 h
Psychostimulant administration increases 50 kHz USVs reflecting positive affect (Ahrens et al., 2009 ). We measured USVs at 1 h and 24 h after MDPV administration (Fig. 7C) . A two-way ANOVA with repeated measures revealed a significant main effect of drug treatment (F 2,19 ¼ 4.4 p ¼ 0.03). Dunnett's multiple comparison test indicated that at one h, 3 mg/kg, but not 1 mg/kg MDPV, increased the number of USVs relative to saline controls (q 38 ¼ 3.3 p ¼ 0.004). This effect of MDPV was no longer observed at 24 h.
MDPV produced deficits in social interactions but not affective vocalizations at 24 h
A prominent effect of psychostimulant-induced adverse effects, such as psychosis, is social withdrawal and drugs such as amphetamine significantly impair social interaction in rats, when given acutely (Sams-Dodd, 1998). We measured social interactions 24 h after MDPV. There was a significant main effect of test session in the social interaction test (two-way ANOVA F 1,15 ¼ 23.9 p ¼ 0.0002) and a significant drug Â session interaction (two-way ANOVA F 2,15 ¼ 4.1 p ¼ 0.03) (Fig. 7D ). Sidak's multiple comparison test indicated that saline and 1 mg/kg treated rats spent less time in anogenital exploration of the stimulus rat in the second session compared to the first session (saline: t 15 ¼ 4.1 p ¼ 0.003; 1 mg/kg MDPV: t 15 ¼ 3.8 p ¼ 0.005), suggesting intact recall of the stimulus rat from the first encounter. Rats given 3 mg/kg MDPV did not show differential exploration of the stimulus rat between first and second test session (t 15 ¼ 0.5 p ¼ 0.9) (Fig. 7D) . It should be noted, however, that this effect appears to be due to a lower social interaction in the first session in rats administered 3 mg/kg MDPV.
Discussion
Our results show that MDPV produces neuroimaging and biochemical changes that persisted at least for 24 h. At 24 h following MDPV administration, we observed increased functional connectivity involving cortical, striatal and limbic regions, and significant alterations in the subcellular levels of membrane and vesicular DA transporter proteins in striatum. Network analyses indicated that MDPV increased clustering coefficient, rich club participation and mean path lengths at the 24 h time point. Among high degree nodes showing increased correlated BOLD activity at 24 h were the amygdala, dorsal and ventral striatum, hypothalamus, prefrontal and somatosensory cortices. We also observed downregulation of striatal DAT and VMAT2 24 h after MDPV treatment, with increased DA turnover (as demonstrated by the increased DOPAC and DOPAC/DA and HVA/DA ratios). Further, subcellular fractionation experiments provide evidence that instead of an overall reduction in DAT/VMAT2 levels, these proteins are increased in membrane and endosomal compartments. This suggests the possibility of internalization and/or altered regulation of DAT/VMAT2 distribution within striatal DA terminals. In support of this possibility, we further observed in a live cell preparation expressing hDAT that MDPV induced internalization of DAT within 60 min, suggesting a rapid regulation of this protein. Collectively, the findings of these multiple experiments suggest that prolonged binding of MDPV to DAT induces internalization, which could affect striatal DA homeostatic regulation and functional interactions between cortical and striatal brain regions.
A possible mechanism contributing to the adverse reactions to MDPV
While case series reports indicate that MDPV, like other drugs of abuse, may produce adverse behavioral effects in users (Beck et al., 2015; Diestelmann et al., 2018; Karila et al., 2018; Vallersnes et al., 2016) , only few preclinical rodent studies focus on determining the potential mechanisms for these effects Merluzzi et al., 2014; Sewalia et al., 2018) . MDPV produces psychostimulant-like behavioral and synaptic effects that are more powerful and longer lasting than cocaine (Aarde et al., 2013; Baumann et al., 2012; Bonano et al., 2014; Gatch et al., 2013; Huang et al., 2012; Marusich et al., 2014; Watterson et al., 2014) . Its primary molecular targets are the dopamine and norepinephrine transporters; thus, it primarily alters mesostriatal monoaminergic neurotransmission (Cozzi et al., 1999) . MDPV is a potent locomotor stimulant (Colon-Perez et al., 2016; Gatch et al., 2013) , produces conditioned place preference (Karlsson et al., 2014; King et al., 2015) , elevates extracellular levels of dopamine in rat striatum (Baumann et al., 2012) , and produces high rates of intravenous selfadministration (IVSA) in rats (Aarde et al., 2013; Watterson et al., 2014) . It also facilitates intracranial self-stimulation (ICSS) (Bonano et al., 2014) . There are, however, studies presenting initial evidence of adverse effects in rodents. Merluzzi et al. reported that Fig. 3 . MDPV administration reduces DAT and VMAT2 protein in striatal tissue 24 h after treatment. A) DAT protein measured as fraction of total protein (in arbitrary units, a.u.). Left plot shows 1 mg/kg and right plot 3 mg/kg, each dose compared to saline control immunoblots. B) TH density for 1 and 3 mg/kg MDPV. C) VMAT2 for same groups as in A and B. All data presented as mean ± s.e. Symbols denote significant difference compared to saline; p < 0.05 t-test). Fig. 4 . MDPV alters subcellular distribution of DAT, TH and VMAT2 in striatum 24 h after exposure. A) DAT, TH and VMAT2 density in subcellular fractions of striatum (in arbitrary units, a.u.; relative to total fraction) of rats administered 1 mg/kg or saline. B) DAT, TH and VMAT2 density in subcellular fractions of striatum (in arbitrary units, a.u.; relative to total fraction) of rats administered 3 mg/kg or saline. All data presented as mean ± s.e. Symbols denote significant differences at p < 0.05*, 0.01** and 0.001*** (t-test). Representative immunoblots for each group is shown in Supplemental Fig. S2 . MDPV (dose range: 1e3 mg/kg) caused conditioned taste aversion to sucrose by the 2nd day of exposure (Merluzzi et al., 2014) . Marusich et al. observed bizarre behaviors in mice after administration of similar MDPV doses . We observed reduced social interactions 24 h after 3 mg/kg MDPV. Intriguingly, at this dose and timepoint, rats showed significantly reduced total striatal dopamine transporter (DAT) protein and altered subcellular distribution. Interestingly, while the functional connectivity effects of MDPV at 1 h overlapped with positive affect, demonstrated by increased number of 50 kHz USV calls and reduced brain reward thresholds, this relationship did not persist at 24 h. Instead, the rewarding effects of MDPV seemed to have subsided by 24 h, although there was still cortical, limbic and striatal functional connectivity and DA changes. It is proposed here that these functional and biochemical changes with acute MDPV exposure are not directly related to alterations in brain reward function and are instead linked to adverse effects, which impacted social interactions at 24 h. A recent study showed that rats undergoing binge MDPV use neurodegenerative changes in entorhinal cortex and impaired novel object recognition memory in rats (Sewalia et al., 2018) . Although a mechanism underlying such effects is still not known, in neuronal and hepatocytic cultures showed cytotoxic effects of catechol-MDPV, one of the main metabolites of 3,4-MDPV, and this may be due to membrane damage and impairment in mitochondrial activity (Wojcieszak et al., 2016) .
MDPV induced changes in functional network topology may contribute to adverse effects
There are a growing number of studies that have applied network analysis to define the effects of drug use on regional brain signal correlations in functional MRI and neurophysiological data sets. Using high-density scalp electroencephalographic (EEG) recordings, Ahmadlou and colleagues showed that methamphetamine (meth) users have higher clustering coefficient and shorter mean path lengths than control subjects (Ahmadlou et al., 2013) . This topological pattern was observed specifically at the EEG gamma band frequency in meth users that abstained for 1e3 weeks. Treatment-seeking cocaine users showed greater node degree and reduced efficiency than control participants (Wang et al., 2015) . This result in cocaine users suggests high functional connectivity, but reduced efficiency and small worldness (i.e. reduced capacity for information transfer across brain regions) (Wang et al., 2015) . In rats, we observed higher clustering and higher mean path lengths with MDPV than in saline controls (at 24 h), which also suggests that the potential for efficient information transfer is reduced by MDPV. Despite partial agreement in these latter results, functional connectivity studies of other drugs of abuse suggest that the impact of drug use on brain topology may be drug-class specific and needs to be interpreted with caution (Ahmadlou et al., 2013; Jiang et al., 2013; Sjoerds et al., 2017; Tagliazucchi et al., 2016) . Rich club topology has been studied in several neuropsychiatric conditions and across studies it appears that impaired connectivity involving hub nodes (which form part of rich club topology) is associated with affective and/or cognitive impairment (Crossley et al., 2014) . For instance, there is a reduced density of rich club connections between midline frontal, parietal, and insular regions in schizophrenia, which is associated with the severity of this disorder (van den Heuvel et al., 2013) . This network metric has been shown to be measured across connectomes of different species (de Reus and van den Heuvel, 2013; Harriger et al., 2012; Liang et al., 2017; Ma et al., 2016; Towlson et al., 2013; van den Heuvel et al., 2016) and may therefore constitute a biomarker of significant evolutionary and clinical translational importance. Animals administered the highest dose of MDPV showed high clustering and path lengths, along with a high rich club participation, compared to saline or cocaine treated rats. This suggests a high segregation or grouping of brain regional correlations, limiting functional interactions with regions outside these groups in separate modules. Consequently, this segregated functional organization pattern, supported by high average path lengths and increased rich club participation, may impose limitations on efficient communication between modules. The behavioral correlates of such network changes and how these may contribute to adverse effects of MDPV is still unclear. However, we observed that the social interaction test showed a significant effect of MDPV at 24 h after exposure. MDPV treated rats showed reduced social interaction at this time point. Although speculative, this could be associated with a lower efficiency in communicating social signals through sensoricortical, amygdalar, hypothalamic and striatal networks. Subregions of the amygdala, such as the medial nucleus, are known to regulate aspects of social interaction in rodents (Coolen et al., 1997) . Interestingly, ascending projections from the basomedial nucleus in the rat include prefrontal cortical and striatal regions, and descending projections are sent to the hypothalamus, specifically to lateral and ventromedial nuclei (Petrovich et al., 1996) . Thus, the inclusion of these regions in the subnetwork of high degree nodes suggests that joint activation of these subcortical areas is involved in reduced social interaction.
Relevance of the distinct immediate (1 h) and prolonged (24 h) network and behavioral effects of MDPV
It is interesting to note parallels in the processing of the rewarding effect of MDPV, as measured by ICSS, and functional connectivity changes reported here and in previous work (Colon-Perez et al., 2016) . ICSS thresholds were reduced at 1 h after MDPV administration (and USVs were elevated), which suggests that the rewarding effect of this drug lasts at least 1 h. However, by 6 h-24 h ICSS thresholds returned to baseline levels (similar to 50 kHz USV calls). Thus, there is overlap between the initial effects of MDPV in disrupting functional connectivity between cortical, striatal and hypothalamic regions (ColonPerez et al., 2016) and the rewarding effects of the drug, as assessed through ICSS and USVs. At 24 h, the rewarding effect of MDPV is lost, which suggests that the increased functional connectivity at 24 h observed in the present study is dissociable from the rewarding effect or changes in reward processing observed at 1 h after exposure. Instead, the reductions in social interaction hint at other aspects of neural processing being affected (as noted in the previous section). It is possible that at the 24 h time point, changes in striatal processing of DA signaling could alter the processing of sensory and social information. We propose that such alterations in neural processing could be associated with the measured DAergic changes in the striatum. There is growing evidence that changes in DA signaling may be critical in modulating functional connectivity between mesocorticolimbic regions (Cole et al., 2012 (Cole et al., , 2013 Febo et al., 2017; Konova et al., 2013) . Striatal DA was previously shown to exert direct effects on the coupling of activity of medium spiny neurons (MSNs), an effect that could impact functional interactions with other brain regions (O'Donnell and Grace, 1993; Onn and Grace, 1994) . Whether such a synaptic and molecular mechanism contributes to the prolonged effects of MDPV on functional connectivity and social interaction in rats remains to be determined. 
Study limitations
There are limitations of the present work that should be mentioned. First, because there were no anatomical tracing studies accompanying our functional MRI datasets, directionality of connectivity and the presence or absence of mono-or polysynaptic connections between regions showing changes in fMRI correlations remains unaddressed. The reported connectome metrics are based on a correlative graph structure constructed from fMRI data, which lacks information on anatomical connectivity. Thus, classification of regions with high degree or high centrality as 'hubs' should be interpreted with care. Because of resolution limitations in fMRI studies, the precision of the reported functional interactions between regions could be supported by applying complementary methods with greater spatial resolution than fMRI (e.g., diffusion MRI, manganese enhanced MRI). We should note that prior data from our lab suggest that the experience of an i.p. injection alone (i.e., of saline) can increase functional connectivity between prefrontal, striatal and somatosensory cortical areas in rats up to 1 h post-injection (Colon-Perez et al., 2016) , suggesting that baseline connectivity measures at 1 h in the present study may have been greater than they would have been in an un-treated animal (or at 24 h). Indeed, a recent report found differences in anxiety-and depression-like behavior in rats resulting from the experience of i.p. injections alone (Aydin et al., 2015) . Although the fact that all rats in the current study had the same injection experience mitigates these concerns, future studies should consider controlling for the effects of pre-scan experimental manipulations on baseline levels of functional connectivity. At 1 h after MDPV or cocaine, we observed significantly reduced clustering and shorter path lengths along with an abnormal pattern of rich club organization (Online Fig. S1 ). This suggests a loss of segregation and functional specialization. However, it is difficult to rule out the possibility that these effects at 1 h are associated with cellular metabolic perturbations following acute psychostimulant exposure at this time point (Downey and Loftis, 2014) . Regarding the reduction in social interaction at 24 h after MDPV administration, this could result from a range of effect that were not studied here. For instance, MDPV has been reported to affect sleep, increase activity for prolonged periods, and lead to rhabdomyolysis in human MDPV users. Along with other effects such as anorexia, anergia, and altered attention, this range of behavioral outcomes of MDPV use contribute to non-specifically reducing social interactions. Finally, while the adverse effects of MDPV are well published, care should be taken to also consider that in some previous clinical reports where MDPV was found to be associated with adverse effects, either MDPV was not confirmed in urine or serum and relied on self-reports, or there was a history of drug use or other mental disorders that may produce adverse outcomes.
Conclusions
The NIDA sponsored 'Monitoring the Future' study reported a prevalence of bath salts use among 12th graders at 1.1% (Johnston et al., 2014) . About a fifth of these students reported chronic use (40 or more times in the past 12 months) (Palamar, 2015) . These ICSS thresholds recover by 6 h. In panel F, asterisks (***p < 0.001) indicate lower ICSS threshold compared to rats treated with vehicle. N ¼ 9/group. All data expressed as mean ± standard error. C) USV calls are increased 1 h after MDPV treatment, but return to control levels by 24 h (Dunnett's test: *p < 0.05 vs saline). D) Time spent in anogenital exploration of a stimulus rat by the test rat during an initial encounter did not differ between saline or 1 mg/kg MDPV; however, it showed a trend towards reduced exploratory activity in rats administered 3 mg/kg MDPV (Dunnett's test: p ¼ 0.05 vs saline in the first test). During a second encounter, the saline and 1 mg/kg MDPV rats reduced the exploration of the stimulus rats (a sign of social recognition; Sidak multiple comparison test: *p < 0.05 vs first session), but this remained unchanged in rats given 3 mg/kg MDPV.
psychoactive synthetic compounds continue to be a national and international concern as new molecular variants emerge (over 77 bath salts identified worldwide) (EMCDDA, 2015) . Functional MRI networks maintain a modular organization, which favors segregation of brain regions with complementary roles (He et al., 2009; Meunier et al., 2009 ). These so-called modules are thought to communicate internally at a high rate and maintain lines of communication with other existing modules. Thus, the elevated level of connectivity observed 24 h after MDPV is interpreted as a highly-segregated network organization, providing for a less efficient network for information transfer. Although a mechanism for this effect of MDPV on network topology remains elusive, we provide initial evidence that altered striatal DAT regulation might be a candidate mechanism. Importantly, the neuroimaging, biochemical and behavioral effects measured in response to MDPV were a result of a transient (acute) exposure, which is rather subtle considering that many reports in humans most often suggest chronic use of MDPV and other bath salts. Although we do not provide evidence here, it is probable that the observed changes are reversible and not corresponding with longer lasting effects of chronic MDPV use. We will seek to determine the effects of chronic MDPV exposure on these measures in future studies using selfadministration models. 
